Position in ARDX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$1,748,121
+$11,225 QoQ
Shares Held
291,840
-2.0% QoQ
Ownership
0.118%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 20%
Shared 0%
None 80%
Common Shares in ARDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. ARDX ranks #97 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in ARDX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,748,121 | 291,840 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,736,896 | 297,924 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,878,292 | 340,888 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,368,601 | 349,133 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,666,630 | 339,436 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $1,653,448 | 326,124 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $2,205,172 | 320,054 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,504,335 | 337,967 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $2,464,290 | 337,574 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,025,936 | 326,764 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,242,131 | 304,444 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,001,050 | 295,295 | Shares | Sole | 2023-08-08 | |
| 2022-03-31 | $104,839 | 97,981 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $104,681 | 95,165 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $128,785 | 97,565 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $713,846 | 94,175 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $563,659 | 85,145 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $618,693 | 95,625 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $446,696 | 85,085 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $681,274 | 98,450 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $550,290 | 96,797 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||